NeOnc Showcases Two Brain Cancer Drug Programs at SNO as FDA Meetings Approach
NeOnc (NASDAQ: NTHI) to present findings from 2 investigational brain cancer programs at the 31st Annual Meeting of the Society for Neuro-Oncology (SNO)
NeOnc (NASDAQ: NTHI) to present findings from 2 investigational brain cancer programs at the 31st Annual Meeting of the Society for Neuro-Oncology (SNO)